Opaleye Management Inc

-

Assets, Funds, Holdings

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Opaleye Management Inc
CRD #124513
SEC #801-78700
CIK #0001595855
AUM 802.8 M (2026-02-19)
Employees 4 (100% Investors, 0% Brokers)
Fees
Minimum
Phone617-229-5085
AddressOne Boston Place
Boston, MA 02108
Source [IAPD] [EDGAR]
Total AUM ($M)
90072054036018002010201520212027
Fees and Compensation — Form ADV Part 2A (2/19/2026) [Brochure]
Item 5.         Fees and Compensation

Fee Structure

We charge a monthly management fee of 2% annually, billed monthly in advance, and a performance-
based allocation of 10% of the first 20% of profits and 20% thereafter, calculated annually and subject to
a high-water mark.

For the Fund, Opaleye directly debits the Fund’s custodial account for management fees. Fees are billed
monthly in advance, based on the net asset value of the Fund as of the first business day of each calendar
month.

Fees for the Managed Account are billed monthly in advance in accordance with the management
agreement, based on the account value as of the first business day of each calendar month.

Opaleye employees may invest in the Fund, and Opaleye typically waives management fees and
performance allocations with respect to such investments.

Fees in General

Opaleye and/or the General Partner may negotiate its fee and elect to waive or reduce the management fee
in whole or in part for any limited partner or the Managed Account.

Account Termination

Investors may not withdraw from the Fund during the first year following their initial investment.
Thereafter, withdrawals may be made at the end of any quarter upon 30 days’ prior written notice, which
may be waived in Opaleye’s sole discretion. Opaleye may also, in its discretion, process withdrawals at the
beginning of any month.

Investors should refer to the Fund’s Offering Documents for a detailed account of termination and
withdrawal provisions.

For the Managed Account, If the Managed Account client wants to terminate the management account
agreement, they must do so in writing. Any excess prepaid fees incurred upon termination will be mutually
agreed upon and reimbursed to the Managed Account.

Other Fees and Expenses
Opaleye’s fees exclude brokerage commissions, transaction fees, markups and markdowns, and other related costs and
expenses, which are borne by the Fund and the Managed Account client. In addition, the Fund and the Managed
Account client may incur certain charges imposed by custodians, brokers, and other third parties such as custodial
fees, transfer taxes, wire transfer and electronic fund fees, and additional fees and taxes on accounts and securities
transactions. Please see Item 12 – Brokerage Practices of this Brochure for important disclosures regarding our
Account Minimums and Types of Clients — Form ADV Part 2A (2/19/2026) [Brochure]
Item 7.        Types of Clients

Opaleye currently provides portfolio management services exclusively to pooled investment vehicles and
the Managed Account, which is a parallel managed account. Pooled investment vehicles are available only
to investors who satisfy certain suitability standards. There is a $1,000,000 minimum investment amount
requirement to invest in the fund, however, Opaleye may accept less at its discretion.
Sector Form 13F Holdings Value ($M)
Transdel Pharmaceuticals Inc 99.9
Liquidia Corp 88.8
Eton Pharmaceuticals Inc 70.6
Sol-Gel Technologies Ltd 39.6
Apogee Therapeutics Inc 32.8
FS Development Corp 26.9
UroGen Pharma Ltd 25.7
Glycomimetics Inc 24.1
Stoke Therapeutics Inc 22.8
Isoray Inc 19.5
View All
Holdings by Sector ($M)
80064048032016002013201720222027
Type Form D Funds Date Sold AUM
HF Opaleye LP [2013-10-09] 42.3 M 789.2 M
Filed 2017-06-07 (D/A) · Exemption 506(b), 3(c), 3(c)(1) · Minimum $50,000 · Remaining Indefinite · Duration More than one year · Net Assets Decline to Disclose
AUM Breakdown Accounts AUM ($M)
By Client Type
(a) Individuals (other than high net worth individuals) 0 0.0
(b) Individuals (high net worth individuals) 0 0.0
(c) Banking or thrift institutions 0 0.0
(d) Investment companies 0 0.0
(e) Business development companies 0 0.0
(f) Pooled investment vehicles 1 789.2
(g) Pension and profit sharing plans 0 0.0
(h) Charitable organizations 0 0.0
(i) State or municipal government entities 0 0.0
(j) Other investment advisers 0 0.0
(k) Insurance companies 0 0.0
(l) Sovereign wealth funds and foreign official institutions 0 0.0
(m) Corporations or other businesses not listed above 1 13.6
(n) Other 0 0.0
Total 2 802.8
By Discretionary
Discretionary 2 802.8
Non-Discretionary 0 0.0
Total 2 802.8
By Non-United States Persons
Non-United States Persons 13.6
United States Persons 789.2
Total 2 802.8
Form D Directors Role # Filings # Firms 2011 - 2026
James Silverman Executive Officer 3 2
Rrc Management LLC Executive Officer 1 1
Opaleye Management Inc Promoter 1 1
Opaleye GP LLC Promoter 1 1
EDGAR Form CIK 2011 - 2026
13F-HR [0001595855]
3 [0001595855]
4 [0001595855]
SC 13D [0001595855]
SC 13G [0001595855]
Form 13D/13G Filer Form 13D/13G Subject Filed
Opaleye Management Inc Pasithea Therapeutics Corp [2026-04-08]
Opaleye Management Inc Q32 Bio Inc [2026-02-20]
Opaleye Management Inc Alpha Cognition Inc [2026-02-06]
Opaleye Management Inc Rezolute Inc [2025-12-19]
Opaleye Management Inc Karyopharm Therapeutics Inc [2025-10-17]
Opaleye Management Inc Alpha Cognition Inc [2025-10-03]
Opaleye Management Inc Larimar Therapeutics Inc [2025-04-16]
Opaleye Management Inc Protara Therapeutics Inc [2024-11-18]
Opaleye Management Inc Codexis Inc [2024-07-12]
Opaleye Management Inc IBIO Inc [2024-04-08]
View All
Firm Profile (Form ADV)
Discretionary AUM$0.2B
ServesInstitutional
Fund TypesHedge Fund
Form 3/4/5 Subject 2011 - 2026
Opaleye Management Inc
Eton Pharmaceuticals Inc
Sol-Gel Technologies Ltd
Alpha Cognition Inc
SANUWAVE Health Inc
Harrow Inc
Codexis Inc
Proteon Therapeutics Inc
Tracon Pharmaceuticals Inc
TELA Bio Inc
View All
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
Alpha Cognition Inc ACOG
Common Stock, no par value
2026-03-30 Buy 1,850 $4.99 9,232
Alpha Cognition Inc ACOG
Common Stock, no par value
2026-03-27 Buy 10,000 $5.08 50,800
Alpha Cognition Inc ACOG
Common Stock, no par value
2026-03-26 Buy 7,319 $5.28 38,644
Alpha Cognition Inc ACOG
Common Stock, no par value
2026-03-25 Buy 8,581 $5.43 46,595
Sol-Gel Technologies Ltd SLGL
Ordinary Shares, par value NIS 1.00 per share.
2026-03-24 Buy 34,665 $72.00 2,495,880
Sol-Gel Technologies Ltd SLGL
Ordinary Shares, par value NIS 1.00 per share.
2026-03-24 Buy 5,000 $72.00 360,000
Alpha Cognition Inc ACOG
Common Stock, no par value
2026-03-24 Buy 4,182 $5.59 23,377
Alpha Cognition Inc ACOG
Common Stock, no par value
2026-03-19 Buy 2,094 $5.71 11,957
Alpha Cognition Inc ACOG
Common Stock, no par value
2026-03-18 Buy 2,481 $5.75 14,266
Alpha Cognition Inc ACOG
Common Stock, no par value
2026-03-16 Buy 1,331 $5.78 7,693
Alpha Cognition Inc ACOG
Common Stock, no par value
2026-03-13 Buy 7,358 $5.75 42,308
Alpha Cognition Inc ACOG
Common Stock, no par value
2026-03-12 Buy 5,708 $5.85 33,392
Alpha Cognition Inc ACOG
Common Stock, no par value
2026-03-09 Buy 2,179 $5.85 12,747
Alpha Cognition Inc ACOG
Common Stock, no par value
2026-03-06 Buy 1,900 $5.80 11,020
Alpha Cognition Inc ACOG
Common Stock, no par value
2026-03-05 Buy 42,023 $5.80 243,733
Alpha Cognition Inc ACOG
Common Stock, no par value
2026-03-05 Buy 5,000 $5.80 29,000
Alpha Cognition Inc ACOG
Common Stock, no par value
2026-03-04 Buy 19,795 $5.81 115,009
Harrow Inc HROW
Common Stock, par value $0.001 per share
2026-03-04 Sell 134,000 $39.67 5,315,780
Harrow Inc HROW
Common Stock, par value $0.001 per share
2026-03-04 Sell 4,263 $39.67 169,113
Alpha Cognition Inc ACOG
Common Stock, no par value
2026-03-03 Buy 46,411 $5.75 266,863
showing 20 of 200 most recent transactions
Comparable Firms State AUM
Divisar Capital Management LLC
CA 812.8 M
NAVI Intl-Administradora E Gestora de Recursos Financeiros LTDA
810.0 M
Willing Capital Management Limited
806.3 M
Masters Capital Management LLC
GA 804.6 M
Nokomis Capital LLC
TX 804.2 M
Barnegat Fund Management Inc
NJ 803.4 M
Net Return Asset Management LLC
NY 803.3 M
Hunters Moon Capital LLP
802.6 M
Saturn V Capital Management LP
TX 793.2 M
KR Capital LP
NY 792.4 M
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com